Paso Program for Fatty Liver Disease
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications. However, if you are on SGLT2 inhibitors or GLP-1 agonists, you must be on a stable dose for at least 6 months before joining the study. Pioglitazone is allowed if you have been on a stable dose for 3 months prior to the study.
What data supports the effectiveness of the Paso Program treatment for fatty liver disease?
Is the Paso Program for Fatty Liver Disease safe for humans?
There is no specific safety data available for the Paso Program itself, but some treatments for fatty liver disease have known side effects. For example, pioglitazone can cause bone thinning and weight gain, while obeticholic acid may cause itching. More research is needed to fully understand the safety of these treatments.678910
How is the Paso Program treatment for fatty liver disease different from other treatments?
The Paso Program for fatty liver disease is unique because it likely involves a structured, multidisciplinary approach that focuses on weight management, which is crucial for improving fatty liver disease. Unlike standard drug treatments, this program may emphasize lifestyle changes and support, making it more comprehensive and potentially more effective for long-term management.34111213
What is the purpose of this trial?
The purpose of this study is to learn whether the Paso weight loss program is feasible for Mexican and Central American patients with fatty liver disease. In addition, the investigators will also look at whether the program improves weight loss, fatty liver disease, physical activity, diet, and family support among patients.
Research Team
Maya Balakrishnan
Principal Investigator
Baylor College of Medicine
Eligibility Criteria
This trial is for Mexican & Central American individuals with fatty liver disease linked to metabolic dysfunction, such as being overweight or having diabetes. It aims to see if the Paso weight loss program can help them.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the Paso weight loss program, consisting of 16 1-hour group counseling classes over 6 months, focusing on healthy eating, physical activity, and behavioral strategies.
Follow-up
Participants are monitored for changes in weight, liver health, and other health metrics at 4 time points over 1 year, including 6 months after the program ends.
Treatment Details
Interventions
- Paso Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator